Could Johnson & Johnson’s talcum powder litigation, now in its second decade, come to an end in 2025? Or are more legal and legislative battles on the horizon? Johnson & Johnson enters the New ...

Johnson & Johnson announced that it has entered into an exclusive licensing agreement for the global development, manufacturing and commercialization of a STAT6 program for autoimmune and allergic ...

Pharmaceutical giant Johnson & Johnson has been hit with bombshell claims the company sold dodgy cold and flu medication to Australians. Brisbane-based law firm JGA Saddler filed a class action ...

Products included several varieties of Codral Cold and Flu, Sudafed PE and Benadryl - all owned by Johnson & Johnson. The firm alleges the company used outdated and fallible studies to sell ...

The Houston Texans on Tuesday waived wide receiver Diontae Johnson as they prepare for their divisional-round playoff game on Saturday against the Kansas City Chiefs. "Unfortunately, with Diontae ...

Jessica Simpson and Eric Johnson were a match made in heaven. The couple met in 2010 and got married four years later and have welcomed three kids together. In January 2025, the “Take My Breath ...

A man in Maine has filed a lawsuit against Johnson & Johnson alleging that the company's talcum powder caused his wife's death. On April 10, 2017, Cynthia Cartwright, Andrew Curtin's wife ...

A class action has been filed against Johnson & Johnson accusing it of selling medicines known to be ineffective. If the action is successful, anyone who bought the products in question since 2005 ...

A man in Maine is suing pharmeceutical giant Johnson & Johnson for $25 million over the death of his wife, claiming that use of its “dangerous and defective” talcum powder caused her death.

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other dividend stocks. Dividend-focused investors are often drawn to stocks with high yields ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other cheap NYSE stocks to invest in now. The stock market appears poised for another year of ...

The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.